DNA or RNA Methylation | Histone Acetylation | Histone Methylation
Epigenetic regulators like DNA, RNA or protein methyltransferases are extensively explored as therapeutic targets since abnormal expression or genomic alterations of these proteins result in various diseases including cancer. Therefore, the inhibition of their enzymatic activity by small molecules is an attractive strategy for cancer treatment.
EpigenTek's unique suite of activity/inhibition assays is designed to make inhibitor screening much simpler, faster, more convenient and more efficient. The most popular activity/inhibition assays are offered with a 10% discount for a limited time, please see product table below.
Innovative technologies and products developed by our partners Epigentek and EpiCypher including kits for the analysis of DNA and RNA methylation as well as chromatin remodeling are offered to facilitate epigenetics research and expand the potential for biomarker discovery.
For epigenomic profiling CUT&RUN, CUT&Tag and ChIP-seq kits are provided.